Clinical Trial Update: Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness of selegiline for cannabis use disorder has completed, assessing efficacy in marijuana-dependent individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• Selegiline (selegiline)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Marijuana Abuse | Phase 2 | Status: COMPLETED